Clinical Trial Update: Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) [Phase 2]

View source ↗

Summary

Phase 2a study evaluating the safety, tolerability, and pharmacokinetics of PLN-74809 in patients with primary sclerosing cholangitis has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• PLN-74809

Snippet

Sponsor: Pliant Therapeutics, Inc. | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: COMPLETED | Results posted: 2026-01-23